← Back to Clinical Trials
Recruiting NCT06677437

Endovascular Preparation for Kidney Tranplantation

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Renal Failure Chronic
Sponsor Hospices Civils de Lyon
Study Type OBSERVATIONAL
Phase N/A
Enrollment 58
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2024-01-01
Completion 2024-01-01
Interventions
This is an observational and retrospective study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This national study is a feasibility study. It wants to validate all stages of the endovascular preparation of the iliac axis up to the kidney transplant for patients in whom the installation of a tailor-made endoprosthesis was necessary beforehand. These patients are currently at a therapeutic impasse. This strategy of renal transplantation on an iliac artery endoprosthesis could ultimately give them access to the transplant with an improvement in quality of life and survival, for lower costs of care for the hospital and safety. less social than treatment by hemodialysis

Eligibility Criteria

Inclusion Criteria: 1. Patient from 18 to 85 years old (beyond 85 years old, guidance must remain exceptional) 2. Patients with chronic renal failure 3. Waiting for a kidney transplant 4. Who have a vascular contraindication to renal transplantation because of their anatomical constraints. Exclusion Criteria: 1-All criteria contraindicating kidney transplant other than for arterial anatomical problems: All criteria contraindicating kidney transplant other than for arterial anatomical problems: * A progressive cancer, which is not cured, * An uncontrolled infectious disease, * Severe cardiovascular or respiratory disease making general anesthesia impossible, * Unstabilized psychiatric disorders or illness, * Dementia proven to have progressed after specialist advice * Major obesity, with a body mass index greater than 50 kg/m2 * Patient refusal 2. Patient under curatorship 3. Pregnant woman 4. Patients for whom it will not be possible to organize regular medical follow-up

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}